Hidradenitis Suppurativa (HS) Completed Phase 3 Trials for Adalimumab (DB00051)

Also known as: Hidradenitis Suppurativa / Hidradenitis / Sweat gland inflammation / Acne inversa

IndicationStatusPhase
DBCOND0054533 (Hidradenitis Suppurativa (HS))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01468233Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis SuppurativaTreatment
NCT01468207Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis SuppurativaTreatment
NCT02904902Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis SuppurativaTreatment
NCT01635764Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis SuppurativaTreatment